1. Suicide worldwide in 2019: global health estimates: World Health Organization; 2019 [Available from: https://iris.who.int/bitstream/handle/10665/341728/9789240026643-eng.pdf?sequence=1 .

2. Bantjes J, Iemmi V, Coast E, Channer K, Leone T, McDaid D, et al. Poverty and suicide research in low- and middle-income countries: systematic mapping of literature published in English and a proposed research agenda. Global mental health (Cambridge, England). 2016; 3: e32. [DOI:10.1017/gmh.2016.27]

3. Stack S. Contributing factors to suicide: Political, social, cultural and economic. Preventive Medicine. 2021; 152: 106498. [DOI:10.1016/j.ypmed.2021.106498]

4. United Nations Global SDG Database 2023 [Available from: https://w3.unece.org/SDG/en/Indicator?id=100.

5. Comprehensive Mental Health Action Plan 2013-2030 2021 [Available from: https://iris.who.int/bitstream/handle/10665/345301/9789240031029-eng.pdf?sequence=1.

6. Thirteenth General Programme of Work: World Health Organization 2019 [Available from: https://iris.who.int/bitstream/handle/10665/324775/WHO-PRP-18.1-eng.pdf?sequence=1.

7. LIVE LIFE Initiative for Suicide Prevention 2021 [Available from: https://www.who.int/initiatives/live-life-initiative-for-suicide-prevention.

8. Erlangsen A, Khan M, Su W, Alateeq K, Charfi F, Madsen T, et al. Situation Analysis of Suicide and Self-Harm in the WHO Eastern Mediterranean Region. Archives of suicide research: official journal of the International Academy for Suicide Research. 2024; 28(3): 760-78. [DOI:10.1080/13811118.2023.2262532]

9. Pearce T, Maple M, Wayland S, McKay K, Woodward A, Brooks A, et al. A mixed-methods systematic review of suicide prevention interventions involving multisectoral collaborations. Health Research Policy and Systems. 2022; 20(1): 40. [DOI:10.1186/s12961-022-00835-0]

10. Advocating for national suicide prevention strategies 2024 [Available from: https://www.who.int/activities/advocating-for-national-suicide-prevention-strategies.

11. Core Competency: Capacity Building and Workforce Development 2024 [Available from: https://sprc.org/core-competencies/core-competency-capacity-building-and-workforce-development/.

12. McAuliffe C. Building Capacity for Campus Suicide Prevention: Evaluation of the Campus Suicide Prevention Initiative. Canadian Mental Health Association of BC; 2022.

13. Developing and Maintaining Funding 2024 [Available from: https://communitysuicideprevention.org/element/sustainability/developing-and-maintaining-funding/.

14. Financing: National Action Alliance for Suicide Prevention; 2024 [Available from: https://theactionalliance.org/healthcare/financing.

15. Training manual for surveillance of suicide and self-harm in communities via key informants: World Health Organization; 2022.

16. Huggett C, Gooding P, Haddock G, Quigley J, Pratt D. The relationship between the therapeutic alliance in psychotherapy and suicidal experiences: A systematic review. Clinical psychology & psychotherapy. 2022; 29(4): 1203-35. [DOI:10.1002/cpp.2726]

17. Huggett C, Peters S, Gooding P, Berry N, Pratt D. A systematic review and meta-ethnography of client and therapist perspectives of the therapeutic alliance in the context of psychotherapy and suicidal experiences. Clinical Psychology Review. 2024; 113: 102469. [DOI:10.1016/j.cpr.2024.102469]

18. Dwivedi Y. The neurobiological basis of suicide. 2012. [DOI:10.1201/b12215]

19. Quevedo LdA, Loret de Mola C, Pearson R, Murray J, Hartwig FP, Gonçalves H, et al. Mental disorders, comorbidities, and suicidality at 30 years of age in a Brazilian birth cohort. Comprehensive Psychiatry. 2020; 102: 152194. [DOI:10.1016/j.comppsych.2020.152194]

20. Masango SM, Rataemane ST, Motojesi AA. Suicide and suicide risk factors: A literature review. South African Family Practice. 2008; 50(6): 25-9. [DOI:10.1080/20786204.2008.10873774]

21. Steele IH, Thrower N, Noroian P, Saleh FM. Understanding Suicide Across the Lifespan: A United States Perspective of Suicide Risk Factors, Assessment & Management. 2018; 63(1): 162-71. [DOI:10.1111/1556-4029.13519]

22. Taliaferro LA, Muehlenkamp JJ. Risk and Protective Factors that Distinguish Adolescents Who Attempt Suicide from Those Who Only Consider Suicide in the Past Year. 2014; 44(1): 6-22. [DOI:10.1111/sltb.12046]

23. Risk and Protective Factors for Suicide: CDC; 2024 [Available from: https://www.cdc.gov/suicide/risk-factors/index.html.

24. Bakken V, Lydersen S, Skokauskas N, Sund AM, Kaasbøll J. Protective factors for suicidal ideation: a prospective study from adolescence to adulthood. European Child & Adolescent Psychiatry. 2024. [DOI:10.1007/s00787-024-02379-w]

25. Rudd MD, Berman AL, Joiner Jr TE, Nock MK, Silverman MM, Mandrusiak M, et al. Warning signs for suicide: Theory, research, and clinical applications. 2006; 36(3): 255-62. [DOI:10.1521/suli.2006.36.3.255]

26. American Psychiatric Association Practice Guideline for the Assessment and Treatment of Patients with Suicidal Behaviors 2003 [Available from: https://zerosuicide.edc.org/resources/resource-database/american-psychiatric-association-practice-guideline-assessment-and.

27. Buzan RD, Weissberg MP. Suicide: risk factors and therapeutic considerations in the emergency department. The Journal of emergency medicine. 1992; 10(3): 335-43. [DOI:10.1016/0736-4679(92)90340-Y]

28. Sarkhel S, Vijayakumar V, Vijayakumar L. Clinical Practice Guidelines for Management of Suicidal Behaviour. Indian journal of psychiatry. 2023; 65(2): 124-30. [DOI:10.4103/indianjpsychiatry.indianjpsychiatry_497_22]

29. Berg SH, Rørtveit K, Walby FA, Aase K. Safe clinical practice for patients hospitalised in mental health wards during a suicidal crisis: qualitative study of patient experiences. 2020; 10(11): e040088. [DOI:10.1136/bmjopen-2020-040088]

30. de Winter RFP, Meijer C, de Groot MH. Treatment of Suicidal Behavior for Inpatients. In: Pompili M, editor. Suicide Risk Assessment and Prevention. Cham: Springer International Publishing; 2021. p. 1-19. [DOI:10.1007/978-3-030-41319-4_67-1]

31. Navin K, Kuppili PP, Menon V, Kattimani S. Suicide Prevention Strategies for General Hospital and Psychiatric Inpatients: A Narrative Review. Indian journal of psychological medicine. 2019; 41(5): 403-12. [DOI:10.4103/IJPSYM.IJPSYM_169_19]

32. Recommended Standard Care for People with Suicide Risk: MAKING HEALTH CARE SUICIDE SAFE. Washington, DC: Education Development Center, Inc.: National Strategy for Suicide Prevention (National Strategy); 2018.

33. Bongar B, Maris RW, Berman AL, Litman RE. Outpatient Standards of Care and the Suicidal Patient. 1992; 22(4): 453-78. [DOI:10.1111/j.1943-278X.1992.tb01039.x]

34. McDowell AK, Lineberry TW, Bostwick JM. Practical suicide-risk management for the busy primary care physician. Mayo Clinic proceedings. 2011; 86(8): 792-800. [DOI:10.4065/mcp.2011.0076]

35. Andreotti ET, Ipuchima JR, Cazella SC, Beria P, Bortoncello CF, Silveira RC, et al. Instruments to assess suicide risk: a systematic review. 2020; 42: 276-81. [DOI:10.1590/2237-6089-2019-0092]

36. Kreuze E, Lamis DAJO-Jod, dying. A review of psychometrically tested instruments assessing suicide risk in adults. 2018; 77(1): 36-90. [DOI:10.1177/0030222816688151]

37. Lotito M, Cook EJMHC. A review of suicide risk assessment instruments and approaches. 2015; 5(5): 216-23. [DOI:10.9740/mhc.2015.09.216]

38. Runeson B, Odeberg J, Pettersson A, Edbom T, Jildevik Adamsson I, Waern MJPo. Instruments for the assessment of suicide risk: A systematic review evaluating the certainty of the evidence. 2017; 12(7): e0180292. [DOI:10.1371/journal.pone.0180292]

39. Sarhadi S, Ghaemi F, Dortaj F, Delavar A. Comparison of the Effectiveness of Sertraline, Transcranial Direct Stimulation Current and their Combination on Post-Traumatic Stress Disorder in Veterans %J the Neuroscience Journal of Shefaye Khatam. 2019; 8(1): 51-62. [DOI:10.29252/shefa.8.1.51]

40. Framework for Suicide Risk Assessment and Management for NSW Health Staff: NSW DEPARTMENT OF HEALTH; 2004.

41. Douglas G. Jacobs MD, Ross J. Baldessarini MD, Yeates Conwell MD, Jan A. Fawcett MD, Leslie Horton MD, Ph.D., Herbert Meltzer MD, et al. PRACTICE GUIDELINE FOR THE Assessment and Treatment of Patients with Suicidal Behaviors. USA: American Psychiatric Association; 2003.

42. Bettis AH, Donise KR, MacPherson HA, Bagatelas P, Wolff JC. Safety Planning Intervention for Adolescents: Provider Attitudes and Response to Training in the Emergency Services Setting. 2020; 71(11): 1136-42. [DOI:10.1176/appi.ps.201900563]

43. Stanley B, Brown GKJC, practice b. Safety planning intervention: a brief intervention to mitigate suicide risk. 2012; 19(2): 256-64. [DOI:10.1016/j.cbpra.2011.01.001]

44. Page SA, King MC. No-Suicide Agreements: Current Practices and Opinions in a Canadian Urban Health Region. The Canadian Journal of Psychiatry. 2008; 53(3): 169-76. [DOI:10.1177/070674370805300307]

45. Edwards SJ, Sachmann MD. No-suicide contracts, no-suicide agreements, and no-suicide assurances: a study of their nature, utilization, perceived effectiveness, and potential to cause harm. Crisis. 2010; 31(6): 290-302. [DOI:10.1027/0227-5910/a000048]

46. Jackson J, Farr M, Birnie K, Davies P, Mamluk L, O'Brien M, et al. Preventing male suicide through a psychosocial intervention that provides psychological support and tackles financial difficulties: A mixed method evaluation. BMC Psychiatry. 2022; 22. [DOI:10.1186/s12888-022-03973-5]

47. Chesin M, Stanley BJBd. Risk assessment and psychosocial interventions for suicidal patients. 2013; 15(5): 584-93. [DOI:10.1111/bdi.12092]

48. Calear AL, Christensen H, Freeman A, Fenton K, Busby Grant J, Van Spijker B, et al. A systematic review of psychosocial suicide prevention interventions for youth. 2016; 25: 467-82. [DOI:10.1007/s00787-015-0783-4]

49. Cox G, Hetrick SJBMH. Psychosocial interventions for self-harm, suicidal ideation and suicide attempt in children and young people: What? How? Who? and Where? 2017; 20(2): 35-40. [DOI:10.1136/eb-2017-102667]

50. Calati R, Lopez-Castroman J. Psychosocial Interventions for Suicide Prevention: Frontiers Media SA; 2020. [DOI:10.3389/978-2-88963-319-7]

51. Miranda R, Jeglic EL. Handbook of Youth Suicide Prevention: Integrating Research into Practice: Springer International Publishing; 2022. [DOI:10.1007/978-3-030-82465-5]

52. Fink M, Kellner CH, McCall WVJTjoE. The role of ECT in suicide prevention. 2014; 30(1): 5-9. [DOI:10.1097/YCT.0b013e3182a6ad0d]

53. Kellner CH, Li EH, Farber KG, Geduldig ET, Ahle GMJCtoip. Electroconvulsive therapy (ECT) and suicide prevention. 2016; 3:73-81. [DOI:10.1007/s40501-016-0067-8]

54. Rönnqvist I, Nilsson FK, Nordenskjöld AJJno. Electroconvulsive therapy and the risk of suicide in hospitalized patients with major depressive disorder. 2021; 4(7): e2116589-e. [DOI:10.1001/jamanetworkopen.2021.16589]

55. Lewitzka U, Severus E, Bauer R, Ritter P, Müller-Oerlinghausen B, Bauer M. The suicide prevention effect of lithium: more than 20 years of evidence-a narrative review. International Journal of Bipolar Disorders. 2015; 3(1): 15. [DOI:10.1186/s40345-015-0032-2]

56. Benard V, Vaiva G, Masson M, Geoffroy PA. Lithium and suicide prevention in bipolar disorder. L'Encephale. 2016; 42(3): 234-41. [DOI:10.1016/j.encep.2016.02.006]

57. Sarai SK, Mekala HM, Lippmann S. Lithium Suicide Prevention: A Brief Review and Reminder. Innovations in clinical neuroscience. 2018; 15(11-12): 30-2.

58. Gibbons RD, Brown CH, Hur K, Davis JM, Mann JJ. Suicidal Thoughts and Behavior with Antidepressant Treatment: Reanalysis of the Randomized Placebo-Controlled Studies of Fluoxetine and Venlafaxine. Archives of General Psychiatry. 2012; 69(6): 580-7. [DOI:10.1001/archgenpsychiatry.2011.2048]

59. Nischal A, Tripathi A, Nischal A, Trivedi JK. Suicide and antidepressants: what current evidence indicates. Mens sana monographs. 2012; 10(1): 33-44. [DOI:10.4103/0973-1229.87287]

60. Baldaçara L, Grudtner RR, da SLV, Porto DM, Robis KP, Fidalgo TM, et al. Brazilian Psychiatric Association guidelines for the management of suicidal behavior. Part 2. Screening, intervention, and prevention. Revista brasileira de psiquiatria (Sao Paulo, Brazil: 1999). 2021; 43(5): 538-49. [DOI:10.1590/1516-4446-2020-1108]

61. Witt K, Potts J, Hubers A, Grunebaum MF, Murrough JW, Loo C, et al. Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials. Australian & New Zealand Journal of Psychiatry. 2019; 54(1): 29-45. [DOI:10.1177/0004867419883341]

62. Abbar M, Demattei C, El-Hage W, Llorca P-M, Samalin L, Demaricourt P, et al. Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo-controlled trial. 2022; 376: e067194. [DOI:10.1136/bmj-2021-067194]

63. Hochschild A, Grunebaum MF, Mann JJ. The rapid anti-suicidal ideation effect of ketamine: A systematic review. Preventive Medicine. 2021; 152: 106524. [DOI:10.1016/j.ypmed.2021.106524]

64. Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, et al. Clozapine Treatment for Suicidality in Schizophrenia: International Suicide Prevention Trial (InterSePT). Archives of General Psychiatry. 2003; 60(1): 82-91. [DOI:10.1001/archpsyc.60.1.82]

65. Sharma V. Atypical antipsychotics and suicide in mood and anxiety disorders. 2003; 5(s2): 48-52. [DOI:10.1111/j.1399-2406.2003.00062.x]

66. Dodds TJ. Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature. The primary care companion for CNS disorders. 2017; 19(2). [DOI:10.4088/PCC.16r02037]

67. Wang C, Wang X, Wang J, Li X, Lu D, Guo F, et al. Prevalence and clinical correlates of benzodiazepine use in the patients with major depressive disorder. Journal of Affective Disorders. 2024; 363: 619-25. [DOI:10.1016/j.jad.2024.07.142]

68. Hassanzadeh M, khajeddin N, Nojomi M, Fleischmann A, Eshrati T. Brief Intervention and Contact after Deliberate Self-Harm: An Iranian Randomized Controlled Trial. 2010; 4(2): 5-12.

69. Fleischmann A, Bertolote JM, Wasserman D, De Leo D, Bolhari J, Botega NJ, et al. Effectiveness of brief intervention and contact for suicide attempters: a randomized controlled trial in five countries. Bulletin of the World Health Organization. 2008; 86(9): 703-9. [DOI:10.2471/BLT.07.046995]